Key facts
- Vivent’s last known valuation is $21.6M (Nov 2021).
- It has raised $13.6M; the latest was Later Stage VC ($8.7M) in Nov 2025.
- Notable investors include Creative Destruction Lab, EIT Food, UK Research and Innovation, Astanor, Start it @KBC — 11 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 11 names
- ·Watchlist + deal alerts for Vivent
- ·The full record, as it builds
Funding rounds
No funding rounds for Vivent are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Vivent
Developer of biosensors designed to optimize climate conditions by managing plant health and gaining insights into how plants communicate. The company aims to tap into plant signaling networks by using artificial intelligence to decipher and provide crop health insights directly from plants to monitor plant electrophysiological signals, enabling greenhouse operators, indoor farms, and perennial crop growers to make agriculture more sustainable and to increase yield by limiting long-duration stress.
- Sector
- Materials and Resources
- HQ
- Gland, Switzerland
- Founded
- 2012
- Employees
- 26
- Website
- vivent-biosignals.com/
- Ownership
- Privately Held (backing)
Vivent doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Vivent shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Vivent in its N-PORT filings yet. We sweep new filings monthly.